过高心肌病:最先进的技术
Steve R Ommen1, Rick A Nishimura1, Hartzell V Schaff2
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Mayo Clinic proceedings
|March 5, 2025
概括
缩性心肌病 (HCM) 管理侧重于改善生活质量和寿命. 现代指导方针和新的疗法,如心脏肌抑制剂,为患有这种遗传性心脏病的患者提供有效的治疗选择.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 内部医学 内部医学
背景情况:
- 增高性心肌病 (HCM) 是最常见的遗传性心肌病.
- 虽然许多患者通过指导方针导向的护理实现了正常的寿命和生活质量,但有些人经历了使人虚弱的症状或危及生命的事件.
- 了解病理生理学是有效管理的关键.
研究的目的:
- 概述目前对高伤心肌病的管理策略.
- 突出全面评估在指导治疗中的作用.
- 讨论现有的医疗和侵入性治疗选择,包括新疗法.
主要方法:
- 使用心声回声,门诊心电图和压力测试进行纵向评估.
- 为特定病例进行心脏磁共振成像.
- 对治疗选择的审查,包括药理学药物和侵入性手术.
主要成果:
- 基于指导方针的护理可以为许多HCM患者带来正常的寿命和良好的生活质量.
- 先进的诊断技术有助于定制治疗计划.
- 心脏肌肉酶抑制剂代表了一种针对HCM细胞机制的新疗法类.
- 侵袭性选择在专家中心进行时,为耐火病例提供了成功的症状缓解.
结论:
- 对于患有多变性心肌病的患者来说,综合和个性化管理至关重要.
- 新的药理和成熟的侵入性治疗方法可以有效地管理症状并改善结果.
- 最终的目标是使HCM患者能够活跃,健康的生活方式.
相关概念视频
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Ischemic Heart Disease: Overview
1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K


